QNTM vs. CSPX.L

Last updated Jun 3, 2026

QNTM (Quantum BioPharma Ltd) is a stock, while CSPX.L (iShares Core S&P 500 UCITS ETF USD (Acc)) is S&P 500 fund tracking the S&P 500 Index. Over the past 5 years, QNTM returned -48.31%/yr vs 13.98%/yr for CSPX.L. At a 0.15 correlation, their price movements are largely independent.

Performance

QNTM vs. CSPX.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quantum BioPharma Ltd (QNTM) and iShares Core S&P 500 UCITS ETF USD (Acc) (CSPX.L). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, QNTM achieves a -30.00% return, which is significantly lower than CSPX.L's 10.91% return.

QNTM

• 1D: -2.67%
• 1M: -7.93%
• YTD: -30.00%
• 6M: -47.32%
• 1Y: -66.38%
• 3Y*: -59.91%
• 5Y*: -48.31%
• 10Y*: —

CSPX.L

• 1D: 0.36%
• 1M: 5.04%
• YTD: 10.91%
• 6M: 12.27%
• 1Y: 30.49%
• 3Y*: 22.54%
• 5Y*: 13.98%
• 10Y*: 15.38%

*Multi-year figures are annualized to reflect compound growth (CAGR)

QNTM vs. CSPX.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
QNTM Quantum BioPharma Ltd	-30.00%	98.37%	-93.84%	16.67%	-22.71%	-34.62%	-71.27%	-87.38%	148.84%
CSPX.L iShares Core S&P 500 UCITS ETF USD (Acc)	10.91%	17.45%	25.25%	26.74%	-18.72%	29.35%	17.62%	30.55%	-8.51%

Correlation

The correlation between QNTM and CSPX.L is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Jun 11, 2018	0.15

Return for Risk

QNTM vs. CSPX.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QNTM

QNTM Risk / Return Rank: 25
QNTM Sharpe Ratio Rank: 22
QNTM Sortino Ratio Rank: 33
QNTM Omega Ratio Rank: 32
QNTM Calmar Ratio Rank: 16
QNTM Martin Ratio Rank: 23

CSPX.L

CSPX.L Risk / Return Rank: 76
CSPX.L Sharpe Ratio Rank: 77
CSPX.L Sortino Ratio Rank: 82
CSPX.L Omega Ratio Rank: 77
CSPX.L Calmar Ratio Rank: 69
CSPX.L Martin Ratio Rank: 76

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QNTM vs. CSPX.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Quantum BioPharma Ltd (QNTM) and iShares Core S&P 500 UCITS ETF USD (Acc) (CSPX.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	QNTM	CSPX.L	Difference
Sharpe ratio Return per unit of total volatility	-0.42	2.53	-2.95
Sortino ratio Return per unit of downside risk	0.12	3.69	-3.57
Omega ratio Gain probability vs. loss probability	1.01	1.46	-0.45
Calmar ratio Return relative to maximum drawdown	-0.66	3.46	-4.12
Martin ratio Return relative to average drawdown	-0.89	14.88	-15.77
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

QNTM vs. CSPX.L - Sharpe Ratio Comparison

The current QNTM Sharpe Ratio is -0.42, which is lower than the CSPX.L Sharpe Ratio of 2.53. The chart below compares the historical Sharpe Ratios of QNTM and CSPX.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	QNTM	CSPX.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.42	2.53	-2.95
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.36	0.87	-1.23
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.95	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.35	0.94	-1.29

Drawdowns

QNTM vs. CSPX.L - Drawdown Comparison

The maximum QNTM drawdown since its inception was -99.98%, which is greater than CSPX.L's maximum drawdown of -33.90%. Use the drawdown chart below to compare losses from any high point for QNTM and CSPX.L.

Drawdown Indicators

	QNTM	CSPX.L	Difference
Max Drawdown Largest peak-to-trough decline	-99.98%	-33.90%	-66.08%
Max Drawdown (1Y) Largest decline over 1 year	-94.00%	-8.17%	-85.83%
Max Drawdown (3Y) Largest decline over 3 years	-97.98%	-18.50%	-79.48%
Max Drawdown (5Y) Largest decline over 5 years	-98.42%	-24.39%	-74.03%
Max Drawdown (10Y) Largest decline over 10 years	—	-33.90%	—
Current Drawdown Current decline from peak	-99.94%	0.00%	-99.94%
Average Drawdown Average peak-to-trough decline	-92.22%	-3.72%	-88.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	69.73%	1.90%	+67.83%

Volatility

QNTM vs. CSPX.L - Volatility Comparison

Quantum BioPharma Ltd (QNTM) has a higher volatility of 54.60% compared to iShares Core S&P 500 UCITS ETF USD (Acc) (CSPX.L) at 3.24%. This indicates that QNTM's price experiences larger fluctuations and is considered to be riskier than CSPX.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	QNTM	CSPX.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	54.60%	3.24%	+51.36%
Volatility (6M) Calculated over the trailing 6-month period	113.44%	8.69%	+104.75%
Volatility (1Y) Calculated over the trailing 1-year period	160.28%	11.83%	+148.45%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	134.24%	15.97%	+118.27%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	140.72%	16.20%	+124.52%

Dividends

QNTM vs. CSPX.L - Dividend Comparison

Neither QNTM nor CSPX.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both QNTM and CSPX.L in my portfolio?

QNTM and CSPX.L have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.